2021 JSGE循证临床实践指南:胃食管反流病

2022-02-28 日本胃肠病学会 J Gastroenterol

作为日本胃食管反流病指南的第三版,本文是对2015年版指南的更新。本次更新中涉及的重要内容包括:将胃食管反流病分为反流性食管炎和非糜烂性反流性疾病的治疗流程,基于反流性食管炎严重程度的治疗以及沃诺拉赞

中文标题:

2021 JSGE循证临床实践指南:胃食管反流病

英文标题:

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021

发布机构:

日本胃肠病学会

发布日期:

2022-02-28

简要介绍:

作为日本胃食管反流病指南的第三版,本文是对2015年版指南的更新。本次更新中涉及的重要内容包括:将胃食管反流病分为反流性食管炎和非糜烂性反流性疾病的治疗流程,基于反流性食管炎严重程度的治疗以及沃诺拉赞的应用。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 JSGE循证临床实践指南:胃食管反流病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e49aa1c0023e09ca, title=2021 JSGE循证临床实践指南:胃食管反流病, enTitle=Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021, guiderFrom=J Gastroenterol, authorId=0, author=, summary=作为日本胃食管反流病指南的第三版,本文是对2015年版指南的更新。本次更新中涉及的重要内容包括:将胃食管反流病分为反流性食管炎和非糜烂性反流性疾病的治疗流程,基于反流性食管炎严重程度的治疗以及沃诺拉赞, cover=https://img.medsci.cn/202231/1646110998757_1608702.jpg, journalId=0, articlesId=null, associationId=1109, associationName=日本胃肠病学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Feb 28 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">作为日本胃食管反流病指南的第三版,本文是对2015年版指南的更新。本次更新中涉及的重要内容包括:将胃食管反流病分为反流性食管炎和非糜烂性反流性疾病的治疗流程,基于反流性食管炎严重程度的治疗以及沃诺拉赞的应用。</span></p>, tagList=[TagDto(tagId=7401, tagName=胃食管反流病), TagDto(tagId=23564, tagName=食管疾病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5211, appHits=219, showAppHits=0, pcHits=731, showPcHits=4991, likes=1, shares=35, comments=6, approvalStatus=1, publishedTime=Tue Mar 01 13:01:07 CST 2022, publishedTimeString=2022-02-28, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Tue Mar 01 13:03:54 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Mon Jan 01 14:23:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 JSGE循证临床实践指南:胃食管反流病.pdf)])
2021 JSGE循证临床实践指南:胃食管反流病.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1203851, encodeId=5bae120385187, content=没有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ed6559353, createdName=ms6000000002837886, createdTime=Fri Mar 18 17:14:44 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202167, encodeId=c59e120216e3a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/6867c483400b413b91cc105516a6220e/372c8c49497a4da5b73d0a57baa73097.jpg, createdBy=998f5411425, createdName=ms7000000932888431, createdTime=Sun Mar 13 09:19:06 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201742, encodeId=557a1201e4255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Fri Mar 11 17:09:02 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201042, encodeId=4cc7120104291, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38992539390, createdName=1251aaefm11(暂无昵称), createdTime=Wed Mar 09 21:34:45 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200341, encodeId=1ce912003411f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f511724803, createdName=1ded443fm18(暂无匿称), createdTime=Mon Mar 07 20:54:09 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
    2022-03-18 ms6000000002837886

    没有中文的吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1203851, encodeId=5bae120385187, content=没有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ed6559353, createdName=ms6000000002837886, createdTime=Fri Mar 18 17:14:44 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202167, encodeId=c59e120216e3a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/6867c483400b413b91cc105516a6220e/372c8c49497a4da5b73d0a57baa73097.jpg, createdBy=998f5411425, createdName=ms7000000932888431, createdTime=Sun Mar 13 09:19:06 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201742, encodeId=557a1201e4255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Fri Mar 11 17:09:02 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201042, encodeId=4cc7120104291, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38992539390, createdName=1251aaefm11(暂无昵称), createdTime=Wed Mar 09 21:34:45 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200341, encodeId=1ce912003411f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f511724803, createdName=1ded443fm18(暂无匿称), createdTime=Mon Mar 07 20:54:09 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
    2022-03-13 ms7000000932888431

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1203851, encodeId=5bae120385187, content=没有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ed6559353, createdName=ms6000000002837886, createdTime=Fri Mar 18 17:14:44 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202167, encodeId=c59e120216e3a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/6867c483400b413b91cc105516a6220e/372c8c49497a4da5b73d0a57baa73097.jpg, createdBy=998f5411425, createdName=ms7000000932888431, createdTime=Sun Mar 13 09:19:06 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201742, encodeId=557a1201e4255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Fri Mar 11 17:09:02 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201042, encodeId=4cc7120104291, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38992539390, createdName=1251aaefm11(暂无昵称), createdTime=Wed Mar 09 21:34:45 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200341, encodeId=1ce912003411f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f511724803, createdName=1ded443fm18(暂无匿称), createdTime=Mon Mar 07 20:54:09 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
    2022-03-11 freegut

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1203851, encodeId=5bae120385187, content=没有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ed6559353, createdName=ms6000000002837886, createdTime=Fri Mar 18 17:14:44 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202167, encodeId=c59e120216e3a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/6867c483400b413b91cc105516a6220e/372c8c49497a4da5b73d0a57baa73097.jpg, createdBy=998f5411425, createdName=ms7000000932888431, createdTime=Sun Mar 13 09:19:06 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201742, encodeId=557a1201e4255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Fri Mar 11 17:09:02 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201042, encodeId=4cc7120104291, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38992539390, createdName=1251aaefm11(暂无昵称), createdTime=Wed Mar 09 21:34:45 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200341, encodeId=1ce912003411f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f511724803, createdName=1ded443fm18(暂无匿称), createdTime=Mon Mar 07 20:54:09 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
    2022-03-09 1251aaefm11(暂无昵称)

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1203851, encodeId=5bae120385187, content=没有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ed6559353, createdName=ms6000000002837886, createdTime=Fri Mar 18 17:14:44 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202167, encodeId=c59e120216e3a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220213/6867c483400b413b91cc105516a6220e/372c8c49497a4da5b73d0a57baa73097.jpg, createdBy=998f5411425, createdName=ms7000000932888431, createdTime=Sun Mar 13 09:19:06 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201742, encodeId=557a1201e4255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Fri Mar 11 17:09:02 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201042, encodeId=4cc7120104291, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38992539390, createdName=1251aaefm11(暂无昵称), createdTime=Wed Mar 09 21:34:45 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200341, encodeId=1ce912003411f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f511724803, createdName=1ded443fm18(暂无匿称), createdTime=Mon Mar 07 20:54:09 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
    2022-03-07 1ded443fm18(暂无匿称)

    学习了

    0